IRIS
LEONI, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.961
EU - Europa 7.945
AS - Asia 6.362
SA - Sud America 1.699
AF - Africa 417
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 10
Totale 29.421
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.755
SG - Singapore 1.941
UA - Ucraina 1.410
VN - Vietnam 1.352
BR - Brasile 1.348
RU - Federazione Russa 1.290
IT - Italia 993
CN - Cina 919
SE - Svezia 860
DE - Germania 768
IE - Irlanda 711
TR - Turchia 677
DK - Danimarca 542
HK - Hong Kong 515
FR - Francia 448
FI - Finlandia 409
KR - Corea 296
GB - Regno Unito 279
CI - Costa d'Avorio 155
IN - India 146
MA - Marocco 127
AR - Argentina 107
BD - Bangladesh 101
CA - Canada 90
MX - Messico 79
IQ - Iraq 61
ZA - Sudafrica 60
CO - Colombia 58
EC - Ecuador 58
ID - Indonesia 55
JP - Giappone 44
PL - Polonia 44
VE - Venezuela 42
UZ - Uzbekistan 36
PK - Pakistan 35
NL - Olanda 33
PH - Filippine 30
BE - Belgio 29
PY - Paraguay 29
ES - Italia 27
EU - Europa 25
AT - Austria 24
CL - Cile 22
JO - Giordania 22
DZ - Algeria 19
MY - Malesia 19
PE - Perù 16
TN - Tunisia 15
CZ - Repubblica Ceca 12
AE - Emirati Arabi Uniti 11
KZ - Kazakistan 11
NP - Nepal 11
RO - Romania 11
ET - Etiopia 10
KE - Kenya 10
UY - Uruguay 10
AZ - Azerbaigian 9
HU - Ungheria 9
LT - Lituania 9
OM - Oman 9
AU - Australia 8
BG - Bulgaria 8
BO - Bolivia 8
SA - Arabia Saudita 8
LB - Libano 7
TH - Thailandia 7
EG - Egitto 6
JM - Giamaica 6
TW - Taiwan 6
CR - Costa Rica 5
IL - Israele 5
IR - Iran 5
AL - Albania 4
CG - Congo 4
CH - Svizzera 4
EE - Estonia 4
GR - Grecia 4
GT - Guatemala 4
PR - Porto Rico 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
NI - Nicaragua 3
SN - Senegal 3
BB - Barbados 2
BH - Bahrain 2
GE - Georgia 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
Totale 29.399
Salva come PNG Salva come JPEG
Città #
Ashburn 1.590
Jacksonville 1.425
Singapore 1.091
Chandler 1.049
Fairfield 779
Dublin 707
Boardman 704
Dallas 701
Hong Kong 495
Wilmington 474
San Jose 455
Ho Chi Minh City 438
New York 367
Woodbridge 351
Houston 310
Seattle 293
San Mateo 291
Hanoi 286
Lawrence 286
Princeton 286
Lauterbourg 252
The Dalles 245
Des Moines 233
Moscow 221
Cambridge 212
Beijing 206
Los Angeles 199
Ann Arbor 189
Hefei 171
Centro 166
Abidjan 155
Milan 129
San Diego 116
São Paulo 112
Buffalo 94
Munich 93
Redmond 93
Helsinki 89
Da Nang 83
Porto 79
Orem 74
Haiphong 54
Turin 53
London 45
Shanghai 45
Miano 39
Santa Clara 39
Tokyo 36
Guangzhou 34
Pune 34
Rio de Janeiro 34
Turku 34
Chicago 33
Curitiba 33
Warsaw 33
Chennai 31
Stockholm 30
Montreal 29
Phoenix 29
Tashkent 29
Brooklyn 28
Hải Dương 28
Norwalk 27
Pianella 27
Brussels 26
Johannesburg 25
Biên Hòa 24
Denver 24
Belo Horizonte 23
Marche 23
Porto Alegre 23
Manchester 22
Mexico City 22
Amman 21
Atlanta 21
Baghdad 21
Nuremberg 21
Poplar 21
Toronto 21
Boston 20
Frankfurt am Main 20
Izmir 20
Rome 19
San Francisco 19
Amsterdam 18
Guayaquil 18
Medellín 18
Ancona 17
Thái Nguyên 17
Auburn Hills 16
Brasília 16
Civitanova Marche 15
Council Bluffs 15
Elk Grove Village 15
Washington 15
Wuhan 15
Campinas 14
Dhaka 14
Guarulhos 14
Quito 14
Totale 17.080
Salva come PNG Salva come JPEG
Nome #
Human white adipocytes convert into “rainbow” adipocytes in vitro 263
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 218
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 211
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 199
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 189
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 178
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 176
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 174
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 174
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 171
Glial-like differentiation potential of human mature adipocytes 169
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 164
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 162
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 161
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 160
Primary B-cell lymphoblastic lymphoma of the testis 159
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 159
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 158
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 154
[Hodgkin's lymphoma and secondary leukemias]. 154
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 152
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: The role of the WHO histological diagnosis 151
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 150
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 150
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 150
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 150
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 148
Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas 148
Meningioma-like cerebral relapse of Hodgkin's disease. 147
Bone marrow adipocytes support haematopoietic stem cell survival 146
Biosafety evidence for human dedifferentiated adipocytes 145
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 144
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 143
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 143
Ematuria ed emospermia ricorrenti: uniche manifestazioni di malattia di von Willebrand di tipo I. First report 143
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 142
Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. 142
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 142
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 141
[Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load]. 141
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 140
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 139
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 139
Plasticity of human dedifferentiated adipocytes toward endothelial cells 138
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 138
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 138
Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides. 138
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 137
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 137
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 137
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 137
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 136
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 135
A circulating T cell clone in early Mycosis Fungoides is not a negative prognostic factor when the disease is treated by a combination of PUVA plus interferon alpha 134
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 133
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 132
[Polychemotherapy versus melphalan-prednisone in multiple myeloma]. 130
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 130
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 130
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase 3 study 129
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 129
A case of monoclonal gammopathy of undetermined significance (MGUS): type IgD-lambda. 128
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 128
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 127
Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: a possible overlapping between micovillous lymphomas and sinusal CD30-positive large B-cell lymphomas. 127
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 127
[Beta 2-microglobulin in lymphoproliferative disorders]. 126
Severe diarrhoea During Campath-1H Treatment For Refractory Cutaneous T Cell Lymphoma 126
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 125
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 125
Molecular and functional characterization of human bone marrow adipocytes 125
[Hairy cell leukemia: therapy with lithium carbonate]. 124
[Peripheral neuropathy associated with Castleman's lymphoma]. 123
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 123
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 122
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 121
Bone marrow extracellular large geometric crystals in IgG/λ MGUS 121
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 121
Central nervous system involvement is a negative prognostic factor in primary cutaneous B-cell lymphoma. 121
Immunostaining for nucleophosmin in bone marrow trephine biopsy specimens in acute myeloid leukemias 120
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 120
CD8+ lymphocytes and CD1a+ dendritic cells in mycosis fungoides: correlation with epidermotropism, subepidermal lymphoid infiltrate, response to therapy and disease recurrence 119
Prognostic clinical, laboratoristic and molecular factors in mycosis fungoides 119
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 119
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 119
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 119
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 118
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 118
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 117
Identification of different adypocytes populations within human marrow microenvironment 117
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 117
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 116
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 116
Early stage Mycosis Fungoides treated with IFNalpha2b and PUVA: molecular analysis of T cell monoclonality by PCR in skin biopsies during and after therapy. 115
Bone Marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients autcome 114
Prospective multicentric Clinical trial on the use of Interferon-a plus PUVA in patients with early stage Mycosis Fungoides. 113
AMIFOSTINE CAN REDUCE MUCOSAL DAMAGE AFTER HIGH-DOSE MELPHALANCONDITIONING FOR PERIPHERAL BLOOD PROGENITOR CELL AUTOTRANSPLANT: A RETROSPECTIVE STUDY. EFFECT OF AMIFOSTINE ON MUCOSITIS DURING AUTOLOGOUS PBPC TRANSPLANTATION 113
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 112
Thalidomide plus oral melphalan for advanced multiple myeloma: a phase Ii study 112
Risk assessment of patients with Hematologic malignancies who develop fever accompanied by pulmonary infiltrates. A historic cohort study. 112
Totale 13.992
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.014
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021146 0 0 0 0 0 0 0 0 0 0 0 146
2021/20222.187 99 620 23 176 16 79 99 171 115 178 158 453
2022/20233.296 343 373 278 258 254 492 1 172 864 19 178 64
2023/20241.955 350 49 102 341 334 369 27 46 5 38 20 274
2024/20253.923 429 424 172 48 169 78 486 113 868 285 353 498
2025/202610.001 707 793 707 1.237 898 726 1.713 1.040 785 765 222 408
Totale 29.782